Resorbable fixation has been invest...

Resorbable fixation has been investigated and documented for use in maxillofacial surgery since the early 1970s(1) The first system that was approved by the US nutriment and Drug Administration in 1996 for clinical use in the United States was a copolymer of polylactic acid and polyglycolic acid. The advantages of using this resorbable technology include

* easily chisel and shaped plates due to its malleable characteristics,

* stout and predictable resorption qualities, and

* improved patient acceptance and expectations. The application of absorbable plating is still in its infancy and can best be compared to the introduction of titanium plates as an alternative to wire osteosynthesis in the mid-1970s.

In the past, the use of metal fixation devices has l to several complications, the major undivided being the potential need for implant removal at a certain quantity of point in the patient's life. Other question at issues with metallic fixation devices are churl and plate migration, growth restriction, radiographic obstruction, and following imaging distortion.(2) Furthermore, some investigations have shown that titanium implanted in the carcass sheds particulate matter into surrounding tissues and alien organs.(3) These complications have created the ne for an improved, nonmetallic fixation material.

RESORBABLE TECHNOLOGY

The materials used for the bioabsorbable implants endure hydrolysis. Water diminishes the integrity of the implants throughout time; therefore, hydrolysis makes the implants more bioabsorbable. Specialized confined apartments known as macrophages rid the material part of the implants as carbon dioxide and water reenter the normal physiological mechanisms at the cellular plain via the Krebs cycle. Bioabsorbable plates and hunkss are completely reabsorbed into the material part within 12 to 15 month with no sign of being implanted. Absorbable implants have proven to be nonpyogenic, nontoxic, nonmutagenic, and nonirritating.

These devices can retain up to 70% of their initial impregnability for up to eight weeks postoperatively. The eight-week period allows for osseous union in the maxillofacial skeleton, after which the implants not ever have to be removed. At 12 month the body's natural metabolism evacuates the copolymer from the surrounding tissue by means of forming carbon dioxide and water, and according to 15 months, the copolymer is completely eliminated.(4)

INDICATIONS FOR SURGERY

Resorbable technology can be used in principally skeletal fixation procedures; however, greatest in number studies focus on craniomaxillofacial repairs. Research in resorbable science has been well documented in American, European, and Asian literature since the 1970s(5) Indications for use in maxillofacial surgery are

* comminuted fractures of the nasoethmoidal and infraorbital areas,

* comminuted fractures of the frontal sinus well,

* trauma of the midface or craniofacial skeleton,

* reconstructive steps of the midface or craniofacial skeleton, or

* orthognathic surgery

This article describes experiences using resorbable fixation in orthognathic surgery (ie, deeds that correct malposition of the jaw bones) These courses include Le Fort I osteotomies (ie, surgical disarticulation of the maxilla for repositioning), bilateral sagittal split osteotomy (ie, splitting of the lower jaw for advancement or setback of the mandible and genioplasties (ie, horizontal osteotomy of the chin for repositioning). In maxillary measures the fixation is performed with resorbable material or L-shaped plates secur with four resorbable hunkss per plate (Figure 1). Candidates for fixation typically are patients who complain of malocclusion, a condition in which the teeth do not clog properly, causing problems with masticating.

[Figure 1 ILLUSTRATION OMITTED]

PREOPERATIVE CARE

Before the day of surgery the surgeon consummateds a history and physical examination. The patient is made aware of the ne for laboratory ordeals (ie, chest x-rays, blood tests) depending onward the results of the physical examination. Preoperative touchstones include complete blood count, urinalysis, and preparation for autologous donation if privationed Autologous blood is rarely necessary as children loss typically is 100 mL to 250 mL The patient's mental status is evaluated to determine compliance with nutritional intake owing to the required soft provisions postoperative diet.

The surgeon evaluates the patient's bony textures for prosthesis space and the size and shape of the alveolar erection The surgeon also evaluates the patient's

* complaints related to prosthetics being used and the patient's reasons for wanting fixation,

* ability and willingness to cooperate with the treatment and following personal care and oral hygiene, and

* general health and his or her medical or surgical risk.

Contraindications for fixation include

* infirm older patients;

* patients who have medical or surgical risks, like as uncontrolled diabetes, immunocompromised vital current dyscrasia, or impaired cardiovascular function;

* patients who mist or have drug or alcohol dependence;